Abstract
Antiphospholipid syndrome (APS) is a serious thrombotic disease characterized by production of autoantibodies against phospholipids, or phospholipid-binding proteins, present in the outer membranes of endothelial cells, monocytes and platelets. Thrombotic events in APS are believed to have a pathophysiological basis as immune reaction in these cell membranes, which causes activation of th…